Akshya Kumar Mahapatra
About Akshya Kumar Mahapatra
Data last updated:
Akshya Kumar Mahapatra is a Director at Gufic Biosciences Limited (since 2024), Additional Director at Omnicals Pharma Private Limited (since 2025) and Director at Tgc Technologies Private Limited (since 2024), and holds 3 more current directorships. The companies operate in Pharma, Business Outsourcing and Information Technology. The 4 current companies with reported revenue have a combined latest revenue of ₹909 Cr; the largest is Gufic Biosciences Limited at ₹823 Cr (FY 2025). Earlier, Akshya Kumar Mahapatra was a Managing Director at Celon Laboratories Private Limited (2022–2024) and Ceo(Kmp) at Delcure Lifesciences Limited (2018–2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Gufic Biosciences Limited L24100MH1984PLC033519 | Director | 14 Nov 2024 | 1984 | ₹823 Cr (FY 2025) | Active |
 Omnicals Pharma Private Limited U33309MH2017PTC294976 | Additional Director | 15 Dec 2025 | 2017 | ₹83.93 Cr (FY 2025) | Active |
 Tgc Technologies Private Limited U74999PN2019PTC181146 | Director | 30 Jun 2024 | 2019 | ₹1.57 Cr (FY 2025) | Active |
 Aleafiaa Pharmaceuticals Private Limited U74999MH2017PTC301818 | Director | 17 Jan 2019 | 2017 | ₹17 Lakh (FY 2024) | Active |
 Quantumbio Institute Of Practical Psychophysics (India) Private Limited U32509MH2026PTC467015 | Director | 29 Jan 2026 | 2026 | Active | |
| Core11 Lifescience Private Limited U86201MH2024PTC434875 | Director | 13 Nov 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Celon Laboratories Private Limited U24232TG2001PTC036097 | Managing Director | 20 Oct 2022 | 2001 | ₹148 Cr (FY 2025) | Active |
 Delcure Lifesciences Limited U24100DL2013PLC286876 | Ceo(Kmp) | 27 Nov 2018 | 2013 | ₹30,000 (FY 2026) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Akshya Kumar Mahapatra
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Akshya Kumar Mahapatra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Akshya Kumar Mahapatra
Akshya Kumar Mahapatra currently holds 6 directorships: Gufic Biosciences Limited (Director, since 14 Nov 2024, revenue ₹823 Cr (FY 2025)); Omnicals Pharma Private Limited (Additional Director, since 15 Dec 2025, revenue ₹83.93 Cr (FY 2025)); Tgc Technologies Private Limited (Director, since 30 Jun 2024, revenue ₹1.57 Cr (FY 2025)); Aleafiaa Pharmaceuticals Private Limited (Director, since 17 Jan 2019, revenue ₹17 Lakh (FY 2024)); Quantumbio Institute Of Practical Psychophysics (India) Private Limited (Director, since 29 Jan 2026); and 1 more.
Akshya Kumar Mahapatra was first appointed on 27 Nov 2018 as Ceo(Kmp) at Delcure Lifesciences Limited. The most recent appointment on record is 29 Jan 2026 at Quantumbio Institute Of Practical Psychophysics (India) Private Limited.
The 4 current companies of Akshya Kumar Mahapatra that report revenue have a combined latest revenue of ₹909 Cr: Gufic Biosciences Limited ₹823 Cr (FY 2025); Omnicals Pharma Private Limited ₹83.93 Cr (FY 2025); Tgc Technologies Private Limited ₹1.57 Cr (FY 2025); Aleafiaa Pharmaceuticals Private Limited ₹17 Lakh (FY 2024).
Akshya Kumar Mahapatra held 2 earlier board appointments: Celon Laboratories Private Limited (Managing Director, 20 Oct 2022 to 15 Feb 2024); Delcure Lifesciences Limited (Ceo(Kmp), 27 Nov 2018 to 20 Mar 2021).
The current boards of Akshya Kumar Mahapatra's companies include Ami Shah (Gufic Biosciences Limited), Anu Sanjiv Aurora (Gufic Biosciences Limited), Devki Nandan Banwarilal Roonghta (Gufic Biosciences Limited), Jayesh Pannalal Choksi (Gufic Biosciences Limited), Kamal Kishore Seth (Gufic Biosciences Limited), Pankaj Jayakumar Gandhi (Gufic Biosciences Limited), among others.